Rankings
▼
Calendar
DAWN FY 2019 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$15M
Net Income
-$13M
EPS (Diluted)
$-0.24
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$111,000
Balance Sheet
Total Assets
$27M
Total Liabilities
$33M
Stockholders' Equity
-$11M
Cash & Equivalents
$27M
← Q1 2020
All Quarters
